Search for: "State Of Washington, Respondent V D. A. B, Appellant" Results 101 - 120 of 129
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2009, 7:23 pm
Gore & Assoc (Chicago Intellectual Property Law Blog) District Court N D Ohio: False patent marking may not be false advertising: Rainworks Ltd v Mill-Rose Co (Rebecca Tushnet's 43(B)log) District Court S D New York: infringement of ‘essential’ patent in patent pool: Koninklijke Philips Electronics N.V. v. [read post]
18 Aug 2011, 11:10 pm by Christa Culver
§ 2254(d)(1) to a state appellate court which held that the evidence was sufficient.Certiorari stage documents:Opinion below (2d Cir.)Petition for certiorariBrief in opposition (forthcoming) Title: Allison v. [read post]
20 May 2016, 9:08 am by John Elwood
Wiesman, 15-862, is a constitutional challenge to Washington regulations that require pharmacies to deliver lawfully prescribed drugs or devices to patients. [read post]
CALIFORNIA WATER RIGHTS AND SUPPLY California WaterFix Extends Public Comment Period To Respond To Pandemic. [read post]
12 May 2009, 12:38 pm
P. 23(b)(3) and in the analogous class action rules of virtually every state. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
13 Dec 2009, 8:58 pm by smtaber
Along the way, he cites Cass Sunstein on the “precautionary principle,” which (per Sunstein) holds that “it is appropriate to respond aggressively to low-probability, high-impact events. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
19 Jul 2010, 3:37 pm by Steven M. Taber
Motz, to felony obstruction of justice charges and violation of the Act to Prevent Pollution from Ships related to concealing deliberate vessel pollution from the M/V Iorana, a Greek flagged cargo ship that made port calls in Baltimore, Tacoma, Wash., and New Orleans. [read post]